THE ROLE OF HUMORAL IMMUNITY ON THE COURSE OF CKD IN PATIENTS WITH TYPE 2  DIABETES WHO HAVE HAD COVID-19

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/11024

Full metadata record

DC Field	Value	Language
dc.contributor.author	Najmutdinova D.K., Mirahmedova X.T., Xudaybergenova D.X.	-
dc.date.accessioned	2024-05-20T11:39:38Z	-
dc.date.available	2024-05-20T11:39:38Z	-
dc.date.issued	2024	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/11024	-
dc.description.abstract	To study the indicators of humoral immunity in patients with type 2 diabetes mellitus (DM) with dia betic nephropathy. Identification of epidemiological and pathophysiological relationships between diabetes mellitus and COVID-19, assessment of prognosis to ensure better treatment results for this category of patients	en_US
dc.language.iso	other	en_US
dc.publisher	Вестник ТМА	en_US
dc.relation.ispartofseries	УДК: 616.379-008.64-06:578.834.;	-
dc.subject	COVID-19, type 2 diabetes mellitus, interleukin, chronic kidney disease	en_US
dc.title	THE ROLE OF HUMORAL IMMUNITY ON THE COURSE OF CKD IN PATIENTS WITH TYPE 2 DIABETES WHO HAVE HAD COVID-19	en_US
dc.title.alternative	GUMORAL IMMUNITETNING COVID-19 BILAN KASALLANGAN 2-TOIFA DIABET BILAN OG’RIGAN BEMORLARDA SURUNKALI BUYRAK KASALLIGIGA TA’SIRI	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
вестник 3. 2024.pdf		1.19 MB	Adobe PDF	View/Open

DSpace JSPUI